Vaxess Technologies, based in Cambridge, MA, is dedicated to transforming access to vaccines and therapeutics through innovative biomedical solutions. Their team of diverse life scientists, engineers, and entrepreneurs is committed to developing groundbreaking technologies that improve human health worldwide.
Utilizing the skin as a delivery pathway, Vaxess' mimix patch delivers bioactive compounds to the body, offering a unique approach to vaccine and therapeutic delivery. By combining immune activating biology with adaptive silk biomaterials, Vaxess is pioneering vaccines and therapeutics that stand out from existing technologies.
Generated from the website